Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | HCP5 |
Upstream (Parents) |
---|
(<<) PYCARD → HCP5 |
(<<) PSMB9 → HCP5 |
(<<) IFITM1 → HCP5 |
(<<) HLA-G → HCP5 |
(<<) IFI27 → HCP5 |
(<<) NCF4 → HCP5 |
(<<) TAP1 → HCP5 |
(<<) CCL3L3///CCL3L1///CCL3 → HCP5 |
Downstream (Children) |
---|
HCP5 → HHIPL2 (>>) |
HCP5 → SEMA4A (>>) |
HCP5 → IFITM1 (>>) |
HCP5 → SECTM1 (>>) |
HCP5 → HLA-G (>>) |
HCP5 → ZCCHC4 (>>) |
HCP5 → ERC1 (>>) |
HCP5 → CAMP (>>) |
HCP5 → HLA-F (>>) |
HCP5 → HCG26 (>>) |